Free Trial

RxSight (RXST) Stock Price, News & Analysis

RxSight logo
$8.32 +0.37 (+4.68%)
As of 01:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About RxSight Stock (NASDAQ:RXST)

Key Stats

Today's Range
$7.65
$8.50
50-Day Range
$7.95
$16.62
52-Week Range
$6.32
$58.23
Volume
2.73 million shs
Average Volume
797,059 shs
Market Capitalization
$338.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.90
Consensus Rating
Reduce

Company Overview

RxSight Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

RXST MarketRank™: 

RxSight scored higher than 47% of companies evaluated by MarketBeat, and ranked 519th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    RxSight has received a consensus rating of Reduce. The company's average rating score is 1.90, and is based on 1 buy rating, 7 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    RxSight has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about RxSight's stock forecast and price target.
  • Earnings Growth

    Earnings for RxSight are expected to grow in the coming year, from ($0.70) to ($0.39) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of RxSight is -12.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of RxSight is -12.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    RxSight has a P/B Ratio of 1.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about RxSight's valuation and earnings.
  • Percentage of Shares Shorted

    13.14% of the float of RxSight has been sold short.
  • Short Interest Ratio / Days to Cover

    RxSight has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in RxSight has recently increased by 3.77%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    RxSight does not currently pay a dividend.

  • Dividend Growth

    RxSight does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.14% of the float of RxSight has been sold short.
  • Short Interest Ratio / Days to Cover

    RxSight has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in RxSight has recently increased by 3.77%, indicating that investor sentiment is decreasing.
  • News Sentiment

    RxSight has a news sentiment score of -0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 31 news articles for RxSight this week, compared to 6 articles on an average week.
  • Search Interest

    7 people have searched for RXST on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added RxSight to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, RxSight insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.57% of the stock of RxSight is held by insiders.

  • Percentage Held by Institutions

    78.78% of the stock of RxSight is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about RxSight's insider trading history.
Receive RXST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter.

RXST Stock News Headlines

RxSight reports Q2 revenue decline, cuts 2025 guidance
RxSight stock plunges after slashing 2025 revenue guidance
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
BTIG Downgrades RxSight (RXST)
Crude Oil Moves Higher; RxSight Shares Plunge
See More Headlines

RXST Stock Analysis - Frequently Asked Questions

RxSight's stock was trading at $34.38 at the start of the year. Since then, RXST stock has decreased by 75.7% and is now trading at $8.34.

RxSight, Inc. (NASDAQ:RXST) posted its quarterly earnings results on Wednesday, May, 7th. The company reported ($0.03) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.03). RxSight's revenue for the quarter was up 28.5% compared to the same quarter last year.
Read the conference call transcript
.

RxSight (RXST) raised $125 million in an initial public offering on Friday, July 30th 2021. The company issued 7,350,000 shares at $16.00-$18.00 per share.

Shares of RXST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that RxSight investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), e.l.f. Beauty (ELF), ServiceNow (NOW), Arista Networks (ANET) and Disc Medicine (IRON).

Company Calendar

Last Earnings
5/07/2025
Today
7/10/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:RXST
CIK
1111485
Fax
N/A
Employees
220
Year Founded
N/A

Price Target and Rating

High Price Target
$73.00
Low Price Target
$9.00
Potential Upside/Downside
+187.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.90
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.45 million
Net Margins
-17.90%
Pretax Margin
-17.86%
Return on Equity
-9.54%
Return on Assets
-8.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.68
Quick Ratio
11.65

Sales & Book Value

Annual Sales
$139.93 million
Price / Sales
2.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.98 per share
Price / Book
1.19

Miscellaneous

Outstanding Shares
40,640,000
Free Float
36,748,000
Market Cap
$337.56 million
Optionable
Optionable
Beta
1.21
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:RXST) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners